PMC:7275137 / 189-301 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T3","span":{"begin":21,"end":29},"obj":"Body_part"}],"attributes":[{"id":"A3","pred":"fma_id","subj":"T3","obj":"http://purl.org/sig/ont/fma/fma63836"}],"text":"viral replication • Lysosome targeting agents and lysosomotropic drugs should be explored as antiviral drugs fo"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T3","span":{"begin":21,"end":29},"obj":"http://purl.obolibrary.org/obo/GO_0005764"}],"text":"viral replication • Lysosome targeting agents and lysosomotropic drugs should be explored as antiviral drugs fo"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T1","span":{"begin":66,"end":71},"obj":"Chemical"},{"id":"T2","span":{"begin":94,"end":109},"obj":"Chemical"},{"id":"T3","span":{"begin":94,"end":103},"obj":"Chemical"},{"id":"T4","span":{"begin":104,"end":109},"obj":"Chemical"}],"attributes":[{"id":"A1","pred":"chebi_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A2","pred":"chebi_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_36044"},{"id":"A3","pred":"chebi_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"},{"id":"A4","pred":"chebi_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"viral replication • Lysosome targeting agents and lysosomotropic drugs should be explored as antiviral drugs fo"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T2","span":{"begin":0,"end":17},"obj":"http://purl.obolibrary.org/obo/GO_0019079"},{"id":"T3","span":{"begin":0,"end":17},"obj":"http://purl.obolibrary.org/obo/GO_0019058"}],"text":"viral replication • Lysosome targeting agents and lysosomotropic drugs should be explored as antiviral drugs fo"}